Overall Technical outlook

Price Summary

Glenmark Pharmaceuticals Limited's stock started trading at 1385.0 on 2025-05-29, climbed to 1424.0, fell to 1380.0, and closed 1.55% higher at 1406.4, with 1055004 shares traded.
The stock's highest price in the past 52 weeks is 1818.15, while its lowest price during the same period is 1122.35.
Analysts expect the price of GLENMARK to vary between 1300.0 and 2011.0, with an average expected price near 1688.3334.

Technicals

Support and Resistance: At 1406.4, the price is supported by 1399.2 and resisted by 1453.2. This indicates that the price for Glenmark Pharmaceuticals Limited might fluctuate between these levels, with 1399.2 acting as a support and 1453.2 limiting further upward movement.
GLENMARK supportResistance e02615
Support/Resistance for GLENMARK


Aroon: The AROON is showing a neutral stance, not indicating a clear upward or downward trend for Glenmark Pharmaceuticals Limited. This suggests a period of market balance, where neither side is showing dominance.
GLENMARK aroon e02615
Aroon chart for Glenmark Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
GLENMARK bbands e02615
Bolinger Bands chart for Glenmark Pharmaceuticals Limited


Parabolic SAR: The PSAR continues its bearish trend, setting a resistance level that could prevent significant upward movement for GLENMARK. This resistance suggests that the market may struggle to overcome bearish forces, keeping upward momentum in check.
GLENMARK psar e02615
Parabolic Stop and Reverse chart for Glenmark Pharmaceuticals Limited


Stochastic: The current state of the STOCHASTIC is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
GLENMARK stoch e02615
Stochastic chart for Glenmark Pharmaceuticals Limited


Tripple Moving Agerage: The Tripple MOVING AVG is neutral, showing no definitive signals of a trend either upward or downward. This neutral stance indicates a period of market indecision, where the direction is unclear.
GLENMARK trippleSMA e02615
Tripple SMA chart for Glenmark Pharmaceuticals Limited


Analyzing the technical indicators of a company, such as stock price and trading volume, requires first understanding its fundamentals. These fundamentals include profitability, growth potential, and market position. Furthermore, knowing the broader industry trends and competitive landscape provides critical context. When both the company's internal data and the external environment are considered, it allows for more meaningful conclusions about the company's technical performance and future trajectory.